About

Making evidence synthesis accessible to everyone.

Axelium was founded to remove the friction from systematic reviews and meta-analyses. We combine deep domain expertise in biostatistics and pharma with modern AI engineering to deliver tools that are transparent, reproducible, and fast.

Mission

Accelerate evidence-based medicine by making systematic reviews 10× faster without sacrificing rigour.

Approach

Every analytical step is auditable. AI assists the researcher — it never replaces their judgement.

Impact

From student research projects to health-technology assessments, Axelium scales to every evidence team.

Leadership

Built by researchers, for researchers.

Co-founder portrait

CPTO and Co-Founder

14 years of experience in AI, Software Engineering and Biomedicine (Illumina, Lifebit, Hitachi Vantara). Launched multiple AI-driven products from idea to revenue.

Co-founder portrait

Co-Founder

Senior pharma executive (Daiichi Sankyo, Kyowa Kirin, Novartis, Abbvie) with 8 years of experience in medical affairs, clinical development and BD/investing. Successfully co-founded previous AI health-tech startups and a biotech accelerator.